When will generic trulicity be available?

Short answer: No generic Trulicity (dulaglutide) is available right now.

What to know:
- Trulicity is a biologic. In the U.S., there’s a separate biosimilar pathway from generics for small-molecule drugs.
- There is 12-year data exclusivity for biologics from the date of first FDA approval. Trulicity was approved in 2014, so the earliest possible time a dulaglutide biosimilar could be approved in the U.S. is around 2026, assuming there are no additional patent protections or legal delays. In reality, it could be later due to patents and litigation.
- Even if a biosimilar is approved, it isn’t automatically interchangeable with Trulicity unless the FDA designates it as interchangeable, which involves extra requirements.

Where to check for updates:
- FDA’s Purple Book (Biosimilar Product Information) for current status on dulaglutide biosimilars.
- Regulatory announcements and major pharmaceutical news.

If you’d like, I can look up the latest status for you.